B. T. Wellde

A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine against<i>Plasmodium falciparum</i><i>Malaria</i>

José A. Stoute, M. Slaoui, D. Gray Heppner et al. · New England Journal of Medicine · 1997 · 879 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Long‐Term Efficacy and Immune Responses following Immunization with the RTS,S Malaria Vaccine

José A. Stoute, Kent E. Kester, Urszula Krzych et al. · The Journal of Infectious Diseases · 1998 · 236 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC‐Pf7, a Pox‐Vectored, Multiantigen, Multistage Vaccine Candidate for<i>Plasmodium falciparum</i>Malaria

Christian F. Ockenhouse, P. Sun, David E. Lanar et al. · The Journal of Infectious Diseases · 1998 · 224 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria

J A Tine, David E. Lanar, Darlene Smith et al. · Infection and Immunity · 1996 · 125 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults

Kent E. Kester, Denise McKinney, Nadia Tornieporth et al. · Vaccine · 2007 · 106 citations

Veterinary Medicine, Infectious Diseases, Pharmacokinetics +15